Time has never been better for Pharma breakthroughs than today: Bayer executive Stefan Oelrich
[ad_1] German pharmaceutical giant Bayer plans to adopt a strong tiered pricing approach worldwide to make its drugs and therapies affordable. However, Stefan Oelrich, head of Bayer’s pharmaceuticals division, in an interview with Vikas Dandekar and Teena Thacker underlined the need for returns on its investments for the risks it takes for research. Edited excerpts:…